Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.29 CAD | +0.64% | +0.64% | -9.63% |
May. 10 | Dentalcorp Posts Higher Q1 Adjusted Net Income | MT |
May. 10 | Dentalcorp Holdings Ltd. Provides Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.20% | 864M | - | ||
-29.37% | 70.3B | B- | ||
+2.04% | 27.46B | C+ | ||
-6.94% | 17.8B | B | ||
+2.21% | 17.46B | A- | ||
+1.81% | 15.46B | A- | ||
+6.36% | 13.49B | B- | ||
+9.93% | 13.06B | A- | ||
+71.34% | 12.96B | C- | ||
+74.04% | 12.56B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DNTL Stock
- Ratings dentalcorp Holdings Ltd.